Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

BIOTRANSFER : revenue, balance sheet and financial ratios

BIOTRANSFER is a French company founded 37 years ago, specialized in the sector Intermédiaires spécialisés dans le commerce d'autres produits spécifiques. Based in MONTREUIL (93100), this company of category PME shows in 2019 a net income positive of 203 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - BIOTRANSFER (SIREN 348786559)
Indicator 2019
Revenue N/C
Net income 203 028 €
EBITDA N/C
Net margin N/C

Revenue and income statement

In 2019, BIOTRANSFER generates positive net income of 203 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2019) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

203 028 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 81%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2019) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2019) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

80.756%

Asset age ratio (2019) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

40.6%

Solvency indicators evolution
BIOTRANSFER

Sector positioning

Debt ratio
0.0 2019
2019
Q1: 0.0
Med: 6.95
Q3: 49.5
Excellent

In 2019, the debt ratio of BIOTRANSFER (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
80.76% 2019
2019
Q1: 11.41%
Med: 35.93%
Q3: 64.94%
Excellent

In 2019, the financial autonomy of BIOTRANSFER (80.8%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 647.40. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2019) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

647.404

Liquidity indicators evolution
BIOTRANSFER

Sector positioning

Liquidity ratio
647.4 2019
2019
Q1: 127.52
Med: 211.43
Q3: 399.51
Excellent

In 2019, the liquidity ratio of BIOTRANSFER (647.40) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of BIOTRANSFER in its sector

Comparison with sector Intermédiaires spécialisés dans le commerce d'autres produits spécifiques

Valuation estimate

Based on 50 transactions of similar company sales (all years), the value of BIOTRANSFER is estimated at 325 725 € (range 227 117€ - 1 118 019€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2019
50 tx
227k€ 325k€ 1118k€
325 725 € Range: 227 117€ - 1 118 019€
NAF 5 all-time

Valuation method used

Net Income Multiple
203 028 € × 1.6x = 325 726 €
Range: 227 118€ - 1 118 019€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 50 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Intermédiaires spécialisés dans le commerce d'autres produits spécifiques)

Compare BIOTRANSFER with other companies in the same sector:

Voir toutes les statistiques du secteur Intermédiaires spécialisés dans le commerce d'autres produits spécifiques

Frequently asked questions about BIOTRANSFER

What is the revenue of BIOTRANSFER ?

The revenue of BIOTRANSFER is not publicly disclosed (confidential accounts filed with INPI).

Is BIOTRANSFER profitable?

Yes, BIOTRANSFER generated a net profit of 203 k€ in 2019.

Where is the headquarters of BIOTRANSFER ?

The headquarters of BIOTRANSFER is located in MONTREUIL (93100), in the department Seine-Saint-Denis.

Where to find the tax return of BIOTRANSFER ?

The tax return of BIOTRANSFER is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does BIOTRANSFER operate?

BIOTRANSFER operates in the sector Intermédiaires spécialisés dans le commerce d'autres produits spécifiques (NAF code 46.18Z). See the 'Sector positioning' section above to compare the company with its competitors.